B. Riley Wealth Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,500
Closed -$112K 1547
2022
Q4
$112K Sell
10,500
-153
-1% -$1.78K ﹤0.01% 1346
2022
Q3
$112K Sell
10,653
-1,672
-14% -$21.8K ﹤0.01% 1309
2022
Q2
$156K Buy
12,325
+175
+1% +$1.86K 0.01% 1079
2022
Q1
$132K Sell
12,150
-400
-3% -$4.86K ﹤0.01% 1266
2021
Q4
$177K Buy
12,550
+750
+6% +$12.3K 0.01% 1290
2021
Q3
$227K Buy
+11,800
New +$157K 0.01% 1185

Other funds holding DVAX

B. Riley Wealth Advisors's DVAX Position: Q1 2023 in Review

B. Riley Wealth Advisors sold out of Dynavax Technologies (DVAX) in Q1 2023, closing a stake of 10,500 shares — an estimated $112K sold.

B. Riley Wealth Advisors first reported a position in DVAX in Q3 2021 and held it in 6 quarters. The position peaked at $227K in Q3 2021. 216 funds tracked by Wall St. Rank hold DVAX as of Q1 2023.

  • B. Riley Wealth Advisors reported no remaining Dynavax Technologies position as of Q1 2023 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 10,500 Dynavax Technologies shares in Q1 2023, an estimated $112K.
  • B. Riley Wealth Advisors first reported a position in Dynavax Technologies in Q3 2021 and held it in 6 quarters.
  • B. Riley Wealth Advisors's Dynavax Technologies position peaked at $227K in Q3 2021.
  • 216 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2023.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2023, filed 17 May 2023.